In a report released on January 5, Steven Valiquette from Mizuho Securities maintained a Buy rating on Cencora (COR – Research Report). The company’s shares closed yesterday at $228.88.
Valiquette covers the Healthcare sector, focusing on stocks such as Cencora, Veeva Systems, and LifeMD. According to TipRanks, Valiquette has an average return of 0.0% and a 52.78% success rate on recommended stocks.
Currently, the analyst consensus on Cencora is a Moderate Buy with an average price target of $275.33.
COR market cap is currently $44.3B and has a P/E ratio of 30.42.
Based on the recent corporate insider activity of 90 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of COR in relation to earlier this year. Last month, Silvana Battaglia, the EVP of COR sold 1,678.00 shares for a total of $383,792.16.
TipRanks tracks over 100,000 company insiders, identifying the select few who excel in timing their transactions. By upgrading to TipRanks Premium, you will gain access to this exclusive data and discover crucial insights to guide your investment decisions. Begin your TipRanks Premium journey today.
Cencora (COR) Company Description:
Cencora, Inc. engages provision of pharmaceutical products and business solutions that improve access
to care. It operates through the Pharmaceutical Distribution Services and Other segments. The Pharmaceutical
Distribution Services segment distributes a comprehensive offering of brand-name, specialty brand-name & generic
pharmaceuticals, over-the-counter healthcare products, home healthcare supplies & equipment, outsourced compounded
sterile preparations, and related services to a wide variety of healthcare providers, including acute care hospitals and
health systems, independent & chain retail pharmacies, mail order pharmacies, medical clinics, long-term care & alternate
site pharmacies, and other customers. The Other segment focuses on global commercialization services and animal health and
includes ABCS, World Courier, and MWI. The company was founded in 1947 and is headquartered in Chesterbrook, PA.
Read More on COR:
- McKesson price target lowered to $650 from $680 at BofA
- Closing Bell Movers: Resources Connection gains 5% on earnings
- Cencora Enhances Leadership with Strategic Acquisition
- Cencora raises FY25 adjusted EPS view to $15.15-$15.45 from $14.80-$15.10
- Cencora completes acquisition of Retina Consultants of America
